METHOD FOR TREATING PURULENT-INFLAMMATORY DISEASES OF UTERINE ADNEXA IN TEENAGERS

FIELD: medicine, gynecology. ^ SUBSTANCE: it is necessary to carry out combined medicinal and physiotherapeutic impact. Mixture of pharmacological preparations consisting of 80 mg gentamycine, 16 U lidase and 4 ml 2%-lidocaine solution should be injected submucosally into lateral vaginal arches foll...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PUTALOVA IRINA NIKOLAEVNA, RUDAKOVA ELENA BORISOVNA, KUCHINSKAJA NATAL'JA VLADIMIROVNA
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, gynecology. ^ SUBSTANCE: it is necessary to carry out combined medicinal and physiotherapeutic impact. Mixture of pharmacological preparations consisting of 80 mg gentamycine, 16 U lidase and 4 ml 2%-lidocaine solution should be injected submucosally into lateral vaginal arches followed by dynamic electroneurostimulation in area of uterine adnexa projection for 30 min. Therapy course lasts for 7 d. The innovation enables to shorten therapy terms and prevent the development of complications due to applying physiotherapeutic impact in acute period of purulent-inflammatory process. ^ EFFECT: higher efficiency of therapy.